Antigenics to Release Earnings on Tuesday April 24, 2001 Conference Call to Follow

Apr 16, 2001, 01:00 ET from Antigenics Inc.

    NEW YORK, April 16 /PRNewswire/ -- Antigenics Inc. (Nasdaq: AGEN) will
 release its first quarter 2001 financial results before the market opens on
 Tuesday April 24, 2001.
     Antigenics executives, including Chairman and CEO, Garo Armen, Ph.D., will
 host a conference call at 11:00 am EDT.
     To access the live call, please dial 877-416-2362 (US) or (706)-679-3010
 (international).  A replay will be available approximately 2 hours after the
 call through midnight EDT on May 4, 2001.  For access, please call
 706-645-9291 and enter access code 676542.
     Antigenics Inc. is developing treatments for cancers, serious infections
 and degenerative disorders using its proprietary technologies that program the
 immune system and improve the quality of life.  For more information about the
 company visit http://www.antigenics.com.
 
     (Logo:  http://www.newscom.com/cgi-bin/prnh/20000419/NYW038 )
 
 

SOURCE Antigenics Inc.
    NEW YORK, April 16 /PRNewswire/ -- Antigenics Inc. (Nasdaq: AGEN) will
 release its first quarter 2001 financial results before the market opens on
 Tuesday April 24, 2001.
     Antigenics executives, including Chairman and CEO, Garo Armen, Ph.D., will
 host a conference call at 11:00 am EDT.
     To access the live call, please dial 877-416-2362 (US) or (706)-679-3010
 (international).  A replay will be available approximately 2 hours after the
 call through midnight EDT on May 4, 2001.  For access, please call
 706-645-9291 and enter access code 676542.
     Antigenics Inc. is developing treatments for cancers, serious infections
 and degenerative disorders using its proprietary technologies that program the
 immune system and improve the quality of life.  For more information about the
 company visit http://www.antigenics.com.
 
     (Logo:  http://www.newscom.com/cgi-bin/prnh/20000419/NYW038 )
 
 SOURCE  Antigenics Inc.